First Time Loading...
N

NNIT A/S
CSE:NNIT

Watchlist Manager
NNIT A/S
CSE:NNIT
Watchlist
Price: 111.2 DKK -0.36% Market Closed
Updated: May 12, 2024
Section:
 

Relative Value

The Relative Value of one NNIT stock under the Base Case scenario is 96.25 DKK. Compared to the current market price of 111.2 DKK, NNIT A/S is Overvalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NNIT Relative Value
Base Case
96.25 DKK
Overvaluation 13%
Relative Value
Price
N
Worst Case
Base Case
Best Case

Valuation Multiples

1.6
P/S
P/S
Price to Sales
1.6
vs History
4
vs Industry
56
Median 3Y
1.2
Median 5Y
1
Industry
2.4
Forward
0.8
More Details
92.2
P/E
P/E
Price to Earnings
92.2
vs History
9
vs Industry
4
Median 3Y
-8.5
Median 5Y
14
Industry
23.9
Forward
14.4
More Details
3.9
P/OCF
P/OCF
Price to OCF
3.9
vs History
68
vs Industry
49
Median 3Y
3.9
Median 5Y
5
Industry
15.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
39
Median 3Y
-6.5
Median 5Y
8.1
Industry
22.5
More Details
3.3
P/B
P/B
Price to Book Value
3.3
vs History
3
vs Industry
27
Median 3Y
2.3
Median 5Y
2.3
Industry
2.3
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
4
vs Industry
56
Median 3Y
1.2
Median 5Y
1.1
Industry
2.5
Forward
0.8
More Details
6.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.3
vs History
52
vs Industry
37
Median 3Y
5.8
Median 5Y
6.3
Industry
5.3
More Details
24.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
24.2
vs History
4
vs Industry
13
Median 3Y
-67.4
Median 5Y
11.8
Industry
12.9
Forward
13.7
More Details
24.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
24.2
vs History
4
vs Industry
20
Median 3Y
-67.4
Median 5Y
13.1
Industry
17.8
Forward
17.7
More Details
4
EV/OCF
EV/OCF
Enterprise Value to OCF
4
vs History
61
vs Industry
50
Median 3Y
3.9
Median 5Y
5.7
Industry
15.4
More Details
4.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
4.4
vs History
61
vs Industry
41
Median 3Y
3.9
Median 5Y
5.7
Industry
19.6
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
3
vs Industry
43
Median 3Y
1.1
Median 5Y
1.3
Industry
2
More Details

Multiples Across Competitors

NNIT Competitors Multiples
NNIT A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
NNIT A/S
CSE:NNIT
2.8B DKK 1.6 92.2 24.2 24.2
US
Veeva Systems Inc
NYSE:VEEV
32.9B USD 13.9 62.5 62.4 67.2
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
12B AUD 82.3 172.5 118.7 118.7
JP
M3 Inc
TSE:2413
1.1T JPY 4.7 23.8 12.3 13.9
US
Inspire Medical Systems Inc
NYSE:INSP
5B USD 7.5 -316.4 -137.9 -126
US
Doximity Inc
NYSE:DOCS
4.4B USD 9.3 31.6 21 22.4
SE
Sectra AB
STO:SECT B
45.4B SEK 27.7 107 -70.5 -70.5
US
Evolent Health Inc
NYSE:EVH
2.8B USD 1.4 -19.6 23.4 249.3
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
P/E Multiple
Earnings Growth
DK
N
NNIT A/S
CSE:NNIT
Average P/E: 76.7
92.2
N/A
US
Veeva Systems Inc
NYSE:VEEV
62.5
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
172.5
119%
JP
M3 Inc
TSE:2413
23.8
26%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -316.4 N/A
US
Doximity Inc
NYSE:DOCS
31.6
79%
SE
Sectra AB
STO:SECT B
107
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -19.6 N/A
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A
EV/EBITDA Multiple
EBITDA Growth
DK
N
NNIT A/S
CSE:NNIT
Average EV/EBITDA: 62.5
24.2
N/A
US
Veeva Systems Inc
NYSE:VEEV
62.4
211%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
118.7
124%
JP
M3 Inc
TSE:2413
12.3
24%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -137.9 N/A
US
Doximity Inc
NYSE:DOCS
21
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -70.5 N/A
US
Evolent Health Inc
NYSE:EVH
23.4
194%
US
Vocera Communications Inc
NYSE:VCRA
264.4
N/A
EV/EBIT Multiple
EBIT Growth
DK
N
NNIT A/S
CSE:NNIT
Average EV/EBIT: 542.1
24.2
N/A
US
Veeva Systems Inc
NYSE:VEEV
67.2
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
118.7
110%
JP
M3 Inc
TSE:2413
13.9
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -126 N/A
US
Doximity Inc
NYSE:DOCS
22.4
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -70.5 N/A
US
Evolent Health Inc
NYSE:EVH
249.3
2 086%
US
Vocera Communications Inc
NYSE:VCRA
4 233.4
N/A

See Also

Summary
NNIT intrinsic value, competitors valuation, and company profile.
DCF Valuation
NNIT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NNIT stock valuation using valuation multiples.
Wall Street Estimates
NNIT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NNIT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.